Local Early Stage Nasopharyngea
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) The pathological diagnosis of NPC; (2) AJCC2010, UICC2003 installments lower than T2aN0-3M0 (UICC) except oropharyngeal invasion; (3) The primary treatment; (4) Aged 18-70 years old; (5) KPS> 70 points; (6) The normal function of major organs that blood routine and biochemical tests in line with chemoradiotherapy standards; (7) Women of childbearing age must, within 7 days prior to enrollment, pregnancy test (serum or urine), and the results were negative, and are willing to adopt appropriate methods of contraception during the trial. During the trial the use of appropriate methods of contraception for men; (8) Subjects voluntarily participated in the study, written informed consent, compliance, and with the follow-up.
Exclusion criteria
Exclusion criteria: (1) Pregnant and lactating women; (2) Chemoradiotherapy contraindications; (3) Can not be clearly described in the response to treatment; (4) Had received radiotherapy or Inconsistent induction chemotherapy; (5) suffers from mental illness, congestive heart failure, angina, hypertension are not yet control, myocardial infarction less than 6 months, active infectious disease, active peptic ulcer, yet under the control of diabetes and nearly six months taking large dose of the hormone (2 0 mg prednisone or equivalent other hormones) medical complications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Normal organ dose;Short term efficacy;The long-term efficacy;Treatment of toxicit; | — |
Countries
China